AKARI THERAPEUTICS
Akari is a biopharmaceutical company focused on developing inhibitors of acute and chronic inflammation, specifically for the treatment of rare and orphan diseases, in particular those where the complement (C5) or leukotriene (LTB4) systems, or both complement and leukotrienes together, play a primary role in disease progression. Akari's lead drug candidate, Nomacopan (formerly known as Coversin), is a C5 complement inhibitor that also independently and specifically inhibits leukotriene B4 (LTB4) activity. Nomacopan is currently being clinically evaluated in four areas: bullous pemphigoid (BP), thrombotic microangiopathy (TMA), as well as programs in the eye and lung.
AKARI THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2004-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.akaritx.com
Total Employee:
11+
Status:
Active
Contact:
646.350.0702
Email Addresses:
[email protected]
Total Funding:
99.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Anchiano Therapeutics
Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.
CureVac
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.
Dare Bioscience
Daré Bioscience is a healthcare company committed to the development and commercialization of innovative products.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Liquidia Technologies
Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.
Point Biopharma
Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
resTORbio
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
Stealth BioTherapeutics
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
Vanda Pharmaceuticals
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies.
Zensun (Shanghai) Sci & Tech Co.
a biopharmaceutical company focusing on the development of innovative bio-therapeutic.
Zymenex
Zymenex is a Scandinavian biopharmaceutical company focused on the development and commercialization of novel enzyme replacement therapies
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Ray Prudo
Ray Prudo investment in Post-IPO Equity - Akari Therapeutics
Vivo Capital
Vivo Capital investment in Post-IPO Equity - Akari Therapeutics
Venrock
Venrock investment in Post-IPO Equity - Akari Therapeutics
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Akari Therapeutics
QVT Financial
QVT Financial investment in Post-IPO Equity - Akari Therapeutics
Deerfield
Deerfield investment in Post-IPO Equity - Akari Therapeutics
Foresite Capital
Foresite Capital investment in Post-IPO Equity - Akari Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Akari Therapeutics
Key Employee Changes
Official Site Inspections
http://www.akaritx.com Semrush global rank: 4.73 M Semrush visits lastest month: 2 K
- Host name: cloudproxy10158.sucuri.net
- IP address: 192.124.249.158
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
